These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 21767082)
1. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression. Dai Y; Hogan S; Schmelz EM; Ju YH; Canning C; Zhou K Nutr Cancer; 2011; 63(5):795-801. PubMed ID: 21767082 [TBL] [Abstract][Full Text] [Related]
2. Antiproliferative activity of ionic liquid-graviola fruit extract against human breast cancer (MCF-7) cell lines using flow cytometry techniques. Daddiouaissa D; Amid A; Kabbashi NA; Fuad FAA; Elnour AM; Epandy MAKMS J Ethnopharmacol; 2019 May; 236():466-473. PubMed ID: 30853648 [TBL] [Abstract][Full Text] [Related]
3. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer. Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288 [TBL] [Abstract][Full Text] [Related]
5. Whole blueberry powder modulates the growth and metastasis of MDA-MB-231 triple negative breast tumors in nude mice. Adams LS; Kanaya N; Phung S; Liu Z; Chen S J Nutr; 2011 Oct; 141(10):1805-12. PubMed ID: 21880954 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner. Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837 [TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo. Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451 [TBL] [Abstract][Full Text] [Related]
8. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Lee EJ; Oh SY; Sung MK Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442 [TBL] [Abstract][Full Text] [Related]
9. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. Cui W; Zhang S; Shan C; Zhou L; Zhou Z FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162 [TBL] [Abstract][Full Text] [Related]
10. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chun J; Kim YS Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413 [TBL] [Abstract][Full Text] [Related]
12. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates. Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Chen P; Cameron R; Wang J; Vallis KA; Reilly RM J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194 [TBL] [Abstract][Full Text] [Related]
14. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). Takabatake D; Fujita T; Shien T; Kawasaki K; Taira N; Yoshitomi S; Takahashi H; Ishibe Y; Ogasawara Y; Doihara H Int J Cancer; 2007 Jan; 120(1):181-8. PubMed ID: 17036319 [TBL] [Abstract][Full Text] [Related]
15. Anticancer activities of an anthocyanin-rich extract from black rice against breast cancer cells in vitro and in vivo. Hui C; Bin Y; Xiaoping Y; Long Y; Chunye C; Mantian M; Wenhua L Nutr Cancer; 2010; 62(8):1128-36. PubMed ID: 21058201 [TBL] [Abstract][Full Text] [Related]
16. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene. Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of cocoa tea (Camellia ptilophylla) in human hepatocellular carcinoma HepG2 in vitro and in vivo through apoptosis. Yang XR; Wang YY; La KK; Peng L; Song XH; Shi XG; Zhu XF; Leung PC; Ko CH; Ye CX J Nutr Biochem; 2012 Sep; 23(9):1051-7. PubMed ID: 22018604 [TBL] [Abstract][Full Text] [Related]
18. Phytochemical fractions from Prasad SK; Veeresh PM; Ramesh PS; Natraj SM; Madhunapantula SV; Devegowda D J Cancer Res Ther; 2020; 16(6):1235-1249. PubMed ID: 33342779 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo. Zhang Y; Zheng L; Zhang J; Dai B; Wang N; Chen Y; He L Planta Med; 2011 Nov; 77(16):1774-81. PubMed ID: 21614750 [TBL] [Abstract][Full Text] [Related]
20. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]